| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/1998 | US5712312 Melatoninergic receptor ligands, treatment of sleep disorders |
| 01/27/1998 | US5712309 Composition for treatment of hangovers |
| 01/27/1998 | US5712307 Methods of inducing the production of hemoglobin and treating pathologies associated with abnormal hemoglobin activity using phemylacetic acids and derivatives therof |
| 01/27/1998 | US5712305 Antineoplastic cocoa extracts and methods for making and using the same |
| 01/27/1998 | US5712303 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
| 01/27/1998 | US5712302 Treatment of chemotherapy side effects |
| 01/27/1998 | US5712301 Use of dexmedetomidine for treating ethanol-induced neurodegeneration |
| 01/27/1998 | US5712300 Hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
| 01/27/1998 | US5712299 (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl methylamine derivatives |
| 01/27/1998 | US5712298 Bronchodilator agents, treatment of asthma, antiinflammatory, treatment of skin disorders |
| 01/27/1998 | US5712297 Piperdine compounds and their preparation and use |
| 01/27/1998 | US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
| 01/27/1998 | US5712295 Insecticides and parasiticides for plant protection |
| 01/27/1998 | US5712294 Antiinflammatory agents |
| 01/27/1998 | US5712293 Gastrointestinal disorders |
| 01/27/1998 | US5712292 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712287 Method of treating urinary bladder dysfunctions |
| 01/27/1998 | US5712286 Modulators of cytokine synthesis, antirheumatic agents |
| 01/27/1998 | US5712284 Azalicyclooctane derivatives as anti-arrhythmic agents |
| 01/27/1998 | US5712283 Method of inhibiting hyperglycemia and pharmaceutical composition for use therein |
| 01/27/1998 | US5712282 Phosphodiesterase inhibitors |
| 01/27/1998 | US5712280 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 01/27/1998 | US5712279 Inhibitors of microsomal triglyceride transfer protein and method |
| 01/27/1998 | US5712277 Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for the treatment of pain and oedema |
| 01/27/1998 | US5712276 Treating nervous system disorders |
| 01/27/1998 | US5712272 Treatment of neurological disorders with benz(b)azepine compounds |
| 01/27/1998 | US5712271 Method of treating urinary bladder dysfunctions |
| 01/27/1998 | US5712269 M2 receptor ligand for the treatment of neurological disorders |
| 01/27/1998 | US5712268 Beta-lactamase inhibitors |
| 01/27/1998 | US5712265 Administration of pirenzepine, methyl scopolamine and other muscarinin receptor antagonists for treatment of glucose metabolism disorders |
| 01/27/1998 | US5712264 17-spiromethylene steroids |
| 01/27/1998 | US5712262 Use of sphingosine-1-phosphate to suppress programmed cell death |
| 01/27/1998 | US5712260 Estramustine formulations with improved pharmaceutical properties |
| 01/27/1998 | US5712259 NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
| 01/27/1998 | US5712256 Wound healing, yeasts, adenin or adenosine |
| 01/27/1998 | US5712255 Treatment of herpes infections with polysubstituted benzimidazoles |
| 01/27/1998 | US5712253 Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| 01/27/1998 | US5712226 Optically active D-pyridyloxy phenoxy propionate herbicides |
| 01/27/1998 | US5712155 DNA encoding tumor necrosis factor-α and -β receptors |
| 01/27/1998 | US5712130 Process for the isolation of lovastatin |
| 01/27/1998 | US5712129 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 01/27/1998 | US5712123 Mixture having antitumor activities |
| 01/27/1998 | US5712115 Polynucleotide encoding polypeptide with amino acid sequences |
| 01/27/1998 | US5712104 Screening test for cancer, aids/hiv, influenza |
| 01/27/1998 | US5712093 RXR homodimer formation |
| 01/27/1998 | US5712085 5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium |
| 01/27/1998 | US5711983 Dinoflagellate biomass, methods for its production, and compositions containing the same |
| 01/27/1998 | US5711967 Controlled release, multilayer pellets, porous membrane, gastric juice resistant coating |
| 01/27/1998 | US5711966 Method of treating malaria with desbutylhalofantrine |
| 01/27/1998 | US5711962 Transdermal therapeutic system for application of pharmaceuticals onto the skin |
| 01/27/1998 | US5711958 Chain extended lactone-alkylene oxide block polymers |
| 01/27/1998 | US5711957 Use of a porous calcium carbonate based material as support of a growth factor in the preparation of a bioabsorbable implant |
| 01/27/1998 | US5711954 Stable imidazole anti-fungal powder compositions |
| 01/27/1998 | CA2194564C Aqueous risperidone formulations |
| 01/27/1998 | CA2138018C Process and intermediates for bis-aza-bicyclic anxiolytic agents |
| 01/27/1998 | CA2092401C Quaternary ammonium salts derived from chitosan |
| 01/27/1998 | CA2037009C 15-dehydroxy-16-oxoprostaglandins |
| 01/27/1998 | CA2024162C Benzazabicyclo carbamates as novel cholinesterase inhibitors |
| 01/27/1998 | CA2016343C Preparation of diazabicyclic intermediates |
| 01/27/1998 | CA2015632C Stable solutions of rebeccamycin analog and preparations thereof |
| 01/27/1998 | CA1339646C Neplanocin derivatives |
| 01/27/1998 | CA1339645C Pyridinium derivatives, their production and use |
| 01/27/1998 | CA1339644C Method of preparing beta-2',2'-difluoronucleosides |
| 01/26/1998 | CA2210448A1 Novel coumarin quinolone carboxylic acids and processes for the preparation thereof |
| 01/26/1998 | CA2203745A1 Pro-protein converting enzyme |
| 01/24/1998 | CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/22/1998 | WO1998002583A1 Novel catalytic rna molecules |
| 01/22/1998 | WO1998002578A1 Silanol enzyme inhibitors |
| 01/22/1998 | WO1998002546A2 Dna immunization against chlamydia infection |
| 01/22/1998 | WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES |
| 01/22/1998 | WO1998002459A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | WO1998002457A1 Subunit respiratory syncytial virus vaccine preparation |
| 01/22/1998 | WO1998002450A2 6,7-oxygenated steroids and uses related thereto |
| 01/22/1998 | WO1998002447A1 Bromotiacumicin compounds |
| 01/22/1998 | WO1998002446A1 Morpholinyl anthracycline derivatives |
| 01/22/1998 | WO1998002440A1 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes |
| 01/22/1998 | WO1998002438A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002437A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | WO1998002434A1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002433A1 Certain fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 01/22/1998 | WO1998002431A1 cis-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES |
| 01/22/1998 | WO1998002423A1 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 01/22/1998 | WO1998002420A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 01/22/1998 | WO1998002419A1 Cancer cell proliferation inhibitors |
| 01/22/1998 | WO1998002413A1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones |
| 01/22/1998 | WO1998002191A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002188A1 Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 01/22/1998 | WO1998002187A1 Pharmaceutical composition containing acid addition salt of basic drug |
| 01/22/1998 | WO1998002186A1 Inclusion complex containing indole selective serotonin agonist |
| 01/22/1998 | WO1998002183A1 Medicinal compositions |
| 01/22/1998 | WO1998002177A1 Wound healing accelerators |
| 01/22/1998 | WO1998002172A1 Methods of enhancing lean tissue mass and bone mineral content and compositions therefor |
| 01/22/1998 | WO1998002171A1 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 01/22/1998 | WO1998002169A2 Novel formulations for the administration of fluoxetine |
| 01/22/1998 | WO1998002168A1 Complexes of n'-dimethylaminoacetylpartricin a dimethylaminoethylamide, or the salts thereof, and cholesterol 3-sulphate |
| 01/22/1998 | WO1998002167A1 Transdermal application of naturally occurring steriod hormones |
| 01/22/1998 | WO1998002166A1 Adenosine deaminase inhibitors |